rs953043
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001042681.2(RERE):c.-144-57951A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.223 in 152,116 control chromosomes in the GnomAD database, including 4,682 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.22 ( 4682 hom., cov: 31)
Consequence
RERE
NM_001042681.2 intron
NM_001042681.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0340
Publications
12 publications found
Genes affected
RERE (HGNC:9965): (arginine-glutamic acid dipeptide repeats) This gene encodes a member of the atrophin family of arginine-glutamic acid (RE) dipeptide repeat-containing proteins. The encoded protein co-localizes with a transcription factor in the nucleus, and its overexpression triggers apoptosis. A similar protein in mouse associates with histone deacetylase and is thought to function as a transcriptional co-repressor during embryonic development. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
RERE Gene-Disease associations (from GenCC):
- complex neurodevelopmental disorder with or without congenital anomaliesInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorder with or without anomalies of the brain, eye, or heartInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.307 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.223 AC: 33856AN: 151998Hom.: 4682 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
33856
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.223 AC: 33855AN: 152116Hom.: 4682 Cov.: 31 AF XY: 0.222 AC XY: 16483AN XY: 74352 show subpopulations
GnomAD4 genome
AF:
AC:
33855
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
16483
AN XY:
74352
show subpopulations
African (AFR)
AF:
AC:
3451
AN:
41516
American (AMR)
AF:
AC:
2792
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
625
AN:
3470
East Asian (EAS)
AF:
AC:
341
AN:
5184
South Asian (SAS)
AF:
AC:
963
AN:
4818
European-Finnish (FIN)
AF:
AC:
3713
AN:
10546
Middle Eastern (MID)
AF:
AC:
72
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21117
AN:
67980
Other (OTH)
AF:
AC:
444
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1285
2571
3856
5142
6427
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
558
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.